RemeGen Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 150.14 million compared to CNY 4.28 million a year ago. Revenue was CNY 150.14 million compared to CNY 4.28 million a year ago. Net loss was CNY 286.83 million compared to CNY 184.48 million a year ago. Basic loss per share from continuing operations was CNY 0.59 compared to CNY 0.38 a year ago. Diluted loss per share from continuing operations was CNY 0.59 compared to CNY 0.38 a year ago.